Zoetis, Inc. Stock Plummets to New 52-Week Low of $122.00

Zoetis, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 122.00 on November 4, 2025. This marks a significant decline, with the stock's performance over the past year reflecting a decrease of 30.4%. In contrast, the S&P 500 has shown a positive performance of 19.89% during the same period, highlighting the challenges faced by Zoetis in the current market environment.
With a market capitalization of USD 71,581 million, Zoetis operates as a large-cap company within its industry. The stock currently has a price-to-earnings (P/E) ratio of 31.00, indicating its valuation relative to earnings. Additionally, the company boasts a notable dividend yield of 60.56%, which may appeal to income-focused investors. The debt-to-equity ratio stands at 1.03, suggesting a balanced approach to leveraging, while the return on equity is a robust 52.68%. The price-to-book ratio is recorded at 14.38, reflecting the company's valuation in relation to its assets.